Changeflow GovPing Healthcare & Life Sciences Transdiagnostic Dimensional Profiling of Neurod...
Routine Notice Added Final

Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders - NCT07544199

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

A new observational study (NCT07544199) was registered April 22, 2026, investigating cognitive function profiles in children ages 3-11 with neurodevelopmental disorders. The study employs the CRAB (Computerized Reading-related Assessment Battery) digital platform developed by SUPSI and the Université de Genève to assess both domain-general cognitive functions (attention, working memory, executive control) and domain-specific functions (phonological awareness, rapid naming, vocabulary, reading). Participating families receive a coded email link to access the platform, with game-like tasks administered remotely under the supervision of IRCCS Medea in Italy.

“CRAB is a digital platform specifically developed by SUPSI and the Université de Genève to integrate, within a single testing environment, the assessment of the main domain-general and domain-specific cognitive functions underlying neurodevelopmental disorders.”

NIH/NLM , verbatim from source
Published by NIH/NLM on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 734 changes logged to date.

What changed

A new observational study (NCT07544199) titled 'Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders' was registered on ClinicalTrials.gov. The study aims to provide a fine-grained, multidimensional mapping of cognitive profiles in preschool and school-age children (3-11 years) using the CRAB digital assessment platform developed by SUPSI and the Université de Genève. The study evaluates both domain-general cognitive functions and domain-specific functions underlying neurodevelopmental disorders, with participants recruited through IRCCS Medea in Italy.

Healthcare providers and clinical researchers working in pediatric neurodevelopmental assessment should be aware of this study as it represents a transdiagnostic approach to cognitive profiling. The use of a standardized digital platform (CRAB) for both domain-general and domain-specific cognitive assessment may inform future best practices in neurodevelopmental evaluation.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders

Observational NCT07544199 Kind: OBSERVATIONAL Apr 22, 2026

Abstract

In recent years, the growing awareness of the multifactorial nature of neurodevelopmental disorders has stimulated interest in transdiagnostic approaches aimed at investigating underlying etiological mechanisms beyond traditional diagnostic categories. In this context, the present study seeks to provide a transdiagnostic profiling of both domain-general cognitive functions (attention, working memory, executive control) and domain-specific functions (phonological awareness, rapid naming, vocabulary, reading) underlying the main neurodevelopmental disorders in a large sample of preschool and school-age children (3-11 years), through the use of CRAB (Computerized Reading-related Assessment Battery). CRAB is a digital platform specifically developed by SUPSI and the Université de Genève to integrate, within a single testing environment, the assessment of the main domain-general and domain-specific cognitive functions underlying neurodevelopmental disorders. In particular, participating families will receive an email containing a link to access the CRAB platform, which will not include their personal data but rather a code provided by the staff of IRCCS Medea. A screen will open displaying several game-like tasks designed to measure both domain-general and domain-specific cognitive functions, which must be completed by the participating subject. The main objective is to obtain a fine-grained and multidimensional mapping of cognitive profiles prior to the standard diagnostic pro...

Conditions: Neurodevelopmental Disorder (Diagnosis)

Interventions: Neuropsychological assessment

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH/NLM
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Observational study Clinical research Cognitive assessment
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!